Senior In Vivo Pharmacology Scientist, Radiopharmaceuticals

Senior In Vivo Pharmacology Scientist, Radiopharmaceuticals

Full-Time 60000 - 80000 £ / year (est.) No working from home possible
Bicycle Therapeutics

At a Glance

  • Tasks: Lead preclinical evaluations of Bicycle® Radio Conjugates and collaborate with cross-functional teams.
  • Company: Bicycle Therapeutics is a pioneering company based in Greater London focused on innovative cancer therapies.
  • Benefits: Enjoy competitive benefits including annual leave and pension contributions.
  • Other info: Position involves driving projects in the field of radiopharmaceuticals.
  • Why this job: This role offers remote flexibility initially, transitioning to a hybrid model.
  • Qualifications: Seeking a skilled in vivo pharmacologist with experience in scientific execution and data communication.

The predicted salary is between 60000 - 80000 £ per year.

Bicycle Therapeutics, based in Greater London, is seeking a skilled in vivo pharmacologist to drive preclinical evaluations of our Bicycle® Radio Conjugates (BRCs). You will lead projects, collaborating with cross-functional teams to deliver innovative cancer therapies. This role initially offers remote flexibility, progressing to a hybrid model with detailed responsibilities in scientific execution and data communication. Competitive benefits include annual leave, pension contributions, and more.

Senior In Vivo Pharmacology Scientist, Radiopharmaceuticals employer: Bicycle Therapeutics

Bicycle Therapeutics, located in Greater London, is dedicated to developing innovative cancer therapies. Employees benefit from competitive perks like annual leave and pension contributions, while working in a collaborative environment focused on cutting-edge research.

Bicycle Therapeutics

Contact Details:

Bicycle Therapeutics Recruitment Team

We think you need these skills to ace Senior In Vivo Pharmacology Scientist, Radiopharmaceuticals

In Vivo Pharmacology
Preclinical Evaluations
Project Leadership
Cross-Functional Collaboration
Scientific Execution
Data Communication
Cancer Therapies Development